Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinical trial offers hope to CED sufferers
cyrus
"Cyrus’ results are exciting because we now know this surgery can help dogs with severe disease, too."
Dog's sight restored by alternative surgery while researchers strive for a genetic test

A rescue dog's sight has been restored by an alternative new surgery. Meanwhile, US researchers are hoping to develop a genetic test for corneal endothelial dystrophy (CED).

CED is seen more commonly in German short-haired pointers (GSP) than in many other breeds.

A clinical trial being carried out by scientists at the UC Davis School of Veterinary Medicine in California aims to identify and isolate the gene responsible. It is hoped they will then be able to develop a test for dog breeders, so they can avoid the condition being passed down to their puppies.

Ten-year-old GSP Cyrus was enrolled onto the UC Davis trial by his rescue shelter, the NorCal GSP Rescue in California. Due to CED, Cyrus was losing his sight.

Traditionally the only definitive treatment for the condition is a corneal transplant. This surgery is rarely performed due to the high cost of surgery and after care, the risk of complications and lack of suitable donor tissue.

CED causes the degeneration of endothelial cells, which form the innermost part of the cornea and are responsible for pumping fluid out of the cornea, which is essential for maintaining ocular transparency.

The condition leads to swelling of the cornea and can even result in blindness and severe pain caused by secondary complications. Small fluid-filled blisters called bullae also form on the cornea and rupture, causing discomfort.

While Cyrus was taking part in the clinical trial on the genetic components of this condition, Dr Sara Thomasy, who is leading the research, considered whether Cyrus may benefit from an alternative surgery to treat CED.

The surgery involves thinning part of the cornea by removing an aspect of its front or anterior part. A very thin conjunctival advancement flap is then placed over the removed part. The procedure is known as superficial keratectomy and conjunctival advancement hood flap (SKCAHF).

A prior surgery trial saw promising results in nine dogs - one of which was a GSP.

Dr Thomasy was concerned, however, that Cyrus' corneas were thicker than those of any other dog that had undergone the surgery. Despite this, Cyrus underwent the procedure in March 2014 and his vision had markedly improved after three months. He is now living with a new family.

"We did know that the SKCAHF surgery trial had been very successful in other dogs, including another GSP, but that dog had more moderate disease," said Dr. Thomasy. "Cyrus’ results are exciting because we now know this surgery can help dogs with severe disease, too."

The research team are looking for GSPs, German wire-haired pointers and Boston terriers with CED to take part in their genetic trials. For further information contact Dr Thomasy via email at smthomasy@ucdavis.edu.





Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.